# Nexentis Technologies Inc. Common Stock (NXTS)

> Nexentis Technologies Inc. Common Stock (NXTS) trades at $1.58 (-7.06%) as of 7:30:00 PM EST on Nov 20, 2026, -44.27% over the past month. Market cap is $807.68K, with 1.0 days to cover in short interest.

Canonical: https://massive.com/quote/nxts
Data as of: 2026-11-21T00:30:00.138Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$1.58** -0.12 (-7.06%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$1.55** -0.03 (-1.90%)
As of 7:30:00 PM EST on Nov 20, 2026 · After hours

## Stock performance

How Nexentis Technologies Inc. Common Stock (NXTS) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -7.06% |
| 1W | -28.51% |
| 1M | -44.27% |
| YTD | -95.62% |
| 1Y | -95.62% |
| 52-wk range | $1.55 – $119.00 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for NXTS: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $1.55 – $1.74 |
| Open | $1.67 |
| Prev close | $1.70 |
| Volume | 7.77K |
| Market cap | $807.68K |
| Shares out | 475.1K |

## Valuation and profitability ratios

Valuation and profitability ratios for Nexentis Technologies Inc. Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 403.84 |
| P/B | 0.35 |
| P/FCF | — |
| ROE | -755.3% |
| ROA | -92.5% |
| Debt/Equity | 0.18 |
| Div yield | 0.00% |

As of Nov 19, 2026

## Insider trading

[Nexentis Technologies Inc. Common Stock (NXTS) insider trading](https://massive.com/quote/nxts/insider-trading.md): open-market Form 4 buys and sells by Nexentis Technologies Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Nexentis Technologies Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 10, 2026 · Equity compensation grant
  “On November 9, 2026, Nexentis Technologies Inc. (the "Company") issued 72,000 shares of common stock to consultants in consideration of various investor relations and business development services provided to the Company. The issuance of such shares was exempt from registration under the Securities Act of 1933, as amended, in reliance on Section 4(a)(2) thereof as transactions by an issuer not involving a public offering.”
- Nov 6, 2026 · Charter amendment
  “The Company filed with the Secretary of State of the State of Nevada a Certificate of Amendment to its Articles of Incorporation, as amended ... to effect the Reverse Stock Split.”
- Oct 19, 2026 · Equity compensation grant
  “On October 15, 2026, Nexentis Technologies Inc. issued ... 51,000 shares of common stock to a consultant for accounting and controller services ...; (ii) 101,549 shares ... to David Palach, its Chief Executive Officer; (iii) 51,000 shares ... to Lital Barda, its Chief Financial Officer; (iv) an aggregate of 208,639 shares ... to the Company's directors, in each case under its 2022 Share Incentive Plan.”
- Sep 3, 2026 · [Listing deficiency notice](https://massive.com/quote/sec-filings/8-k/delisting-notices.md)
  “On August 31, 2026, Nexentis Technologies Inc. received a letter from the Listing Qualifications Staff of The Nasdaq Capital Market notifying the Company that its stockholders' equity was no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders' equity of at least $2,500,000. As reported on the Form 10-Q, the Company's stockholders' equity as of June 30, 2026 was $1,782,000.”
- Aug 6, 2026 · [Auditor dismissal](https://massive.com/quote/sec-filings/8-k/auditor-changes.md)
  “On August 6, 2026, the board of directors (the "Board") and audit committee of the Board (the "Audit Committee") of Nexentis Technologies Inc. (the "Company") approved the dismissal of Somekh Chaikin, a member firm of KPMG International ("KPMG Israel"), as its independent registered public accounting firm, effective on August 6, 2026.”

## Dividend history and stock splits

Nexentis Technologies Inc. Common Stock's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-5 · Nov 9, 2026
- 1-for-7 · Apr 8, 2026

## NXTS short interest

How heavily NXTS is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 1.0 |
| Short interest | 63.64K |
| Avg volume | 331.23K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## NXTS news

The latest news and headlines about Nexentis Technologies Inc. Common Stock (NXTS).

- [Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board](https://www.globenewswire.com/news-release/2026/09/24/3368223/0/en/nexentis-mitocarex-strengthens-its-computational-drug-discovery-capabilities-with-appointment-of-prof-dan-t-major-to-scientific-advisory-board.html) · GlobeNewswire Inc. · Sep 24, 2026 · positive sentiment

## About Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 9 |
| Listed | Dec 15, 2009 |

[Company website](https://nexentistech.com)

## FAQ

### What is the Nexentis Technologies Inc. Common Stock (NXTS) stock price today?

Nexentis Technologies Inc. Common Stock (NXTS) is trading at $1.58 (-7.06% on the day) as of 7:30:00 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Nexentis Technologies Inc. Common Stock?

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and…

### What is the short interest in NXTS?

As of Oct 30, 2026, NXTS has 63.64K shares short and 1.0 days to cover.

### What exchange is NXTS listed on?

Nexentis Technologies Inc. Common Stock (NXTS) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time NXTS quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=NXTS`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Nexentis Technologies Inc. Common Stock (NXTS) insider trading](https://massive.com/quote/nxts/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
